Secondary analysis of the phase 3 KONFIDENT trial in hereditary angioedema: 44% of attacks caused moderate-to-extreme anxiety, and cumulative anxiety fell significantly more after sebetralstat than placebo (exploratory endpoints).
Secondary analysis
Craig et al. Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema Attacks